Article
The role of the epidermal growth factor in the pathogenesis of schizophrenia. Clinical and diagnostic value.
Growth factors (Chur, Switzerland) - 1 May 2026
Piskareva Daria, Zorkina Yana, Andryushenko Alisa, Kostyuk Georgy
Abstract excerpt
Research increasingly implicates neuroimmune inflammation in schizophrenia, with the epidermal growth factor (EGF) family as a potential link. This review critically evaluates EGF family members as diagnostic, risk, and treatment response markers.The most consistent finding is decreased serum EGF in chronic schizophrenia, confirmed in postmortem brain and independent of antipsychotics. First-episode data are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
